Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer
Credit: Pixabay/CC0 Public Domain In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced...